Abstract
Photodynamic therapy is an evolving treatment modality for cancer owing to its non-invasive approach. This mode of therapy depends on the dynamic interaction of light, oxygen and a photoactive drug to induce oxidative damage to affected cells. This apparently simple technique could be complicated by several factors, mainly contributed by the nature of the physicochemical properties of the photoactive drug, variation in light source and exposure time, as well as tumor physiological environment. This review covers a brief history on the use of various fluorophores in photodynamic therapy, successful marketed formulations and the factors affecting the treatment modalities. The potential of nanostructures as effective delivery carriers with improved photodynamic efficacy is also elaborated. A thorough understanding of the chemistry of photoactive drugs, characteristics of the delivery carriers and light irradiation parameters will enable optimal efficacy of photodynamic therapy.
Keywords: Photodynamic therapy, photosensitizers, nanocarriers, optimized delivery, carcinoma, cancer.
Current Pharmaceutical Design
Title:Implications of Photophysical and Physicochemical Factors on Successful Application of Photodynamic Therapy
Volume: 23 Issue: 40
Author(s): Shubhajit Paul, Paul Wan Sia Heng and Lai Wah Chan*
Affiliation:
- Department of Pharmacy, 18 Science Drive 4, National University of Singapore, 117543,Singapore
Keywords: Photodynamic therapy, photosensitizers, nanocarriers, optimized delivery, carcinoma, cancer.
Abstract: Photodynamic therapy is an evolving treatment modality for cancer owing to its non-invasive approach. This mode of therapy depends on the dynamic interaction of light, oxygen and a photoactive drug to induce oxidative damage to affected cells. This apparently simple technique could be complicated by several factors, mainly contributed by the nature of the physicochemical properties of the photoactive drug, variation in light source and exposure time, as well as tumor physiological environment. This review covers a brief history on the use of various fluorophores in photodynamic therapy, successful marketed formulations and the factors affecting the treatment modalities. The potential of nanostructures as effective delivery carriers with improved photodynamic efficacy is also elaborated. A thorough understanding of the chemistry of photoactive drugs, characteristics of the delivery carriers and light irradiation parameters will enable optimal efficacy of photodynamic therapy.
Export Options
About this article
Cite this article as:
Paul Shubhajit, Heng Wan Sia Paul and Chan Wah Lai *, Implications of Photophysical and Physicochemical Factors on Successful Application of Photodynamic Therapy, Current Pharmaceutical Design 2017; 23 (40) . https://dx.doi.org/10.2174/1381612823666170307104032
DOI https://dx.doi.org/10.2174/1381612823666170307104032 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
Call for Papers in Thematic Issues
"Tuberculosis Prevention, Diagnosis and Drug Discovery"
The Nobel Prize-winning discoveries of Mycobacterium tuberculosis and streptomycin have enabled an appropriate diagnosis and an effective treatment of tuberculosis (TB). Since then, many newer diagnosis methods and drugs have been saving millions of lives. Despite advances in the past, TB is still a leading cause of infectious disease mortality ...read more
Current Pharmaceutical challenges in the treatment and diagnosis of neurological dysfunctions
Neurological dysfunctions (MND, ALS, MS, PD, AD, HD, ALS, Autism, OCD etc..) present significant challenges in both diagnosis and treatment, often necessitating innovative approaches and therapeutic interventions. This thematic issue aims to explore the current pharmaceutical landscape surrounding neurological disorders, shedding light on the challenges faced by researchers, clinicians, and ...read more
Emerging and re-emerging diseases
Faced with a possible endemic situation of COVID-19, the world has experienced two important phenomena, the emergence of new infectious diseases and/or the resurgence of previously eradicated infectious diseases. Furthermore, the geographic distribution of such diseases has also undergone changes. This context, in turn, may have a strong relationship with ...read more
Melanoma and Non-Melanoma Skin Cancer Treatment: Standard of Care and Recent Advances
In this thematic issue, we aim to provide a standard of care of the diagnosis and treatment of melanoma and non-melanoma skin cancer. The editor will invite authors from different countries who will write review articles of melanoma and non-melanoma skin cancers. The Diagnosis, Staging, Surgical Treatment, Non-Surgical Treatment all ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Novel Non-Invasive Protein and Peptide Drug Delivery Approaches
Protein & Peptide Letters Inhibition of Autophagy by Targeting ATG4B: Promises and Challenges of An Emerging Anti-cancer Strategy
Clinical Cancer Drugs Therapeutic Targeting of Cancers with Loss of PTEN Function
Current Drug Targets Topical Imiquimod: Mechanism of Action and Clinical Applications
Mini-Reviews in Medicinal Chemistry Cytochromes P450 and Skin Cancer: Role of Local Endocrine Pathways
Anti-Cancer Agents in Medicinal Chemistry Nucleic Acid-based Technologies in Therapy of Malignant Gliomas
Current Pharmaceutical Biotechnology Anti-Seizure Medications and Estradiol for Neuroprotection in Epilepsy: The 2013 Update
Recent Patents on CNS Drug Discovery (Discontinued) Inhibition of Angiogenesis by Non-Steroidal Anti-Inflammatory Drugs: From the Bench to the Bedside and Back
Current Drug Targets - Inflammation & Allergy The Blood-Brain Barrier: Its Influence in the Treatment of Brain Tumors Metastases
Current Cancer Drug Targets Role of Chemokines and Their Receptors in Cancer
Current Pharmaceutical Design RAS/RAF/MEK Inhibitors in Oncology
Current Medicinal Chemistry Organoselenium Compounds in Cancer Chemoprevention
Mini-Reviews in Medicinal Chemistry The High Mobility Group A1 (HMGA1) Transcriptome in Cancer and Development
Current Molecular Medicine Cellular and Biochemical Alterations Caused by Artificial Depletion of Glutathione
Current Enzyme Inhibition Involvement of the Mitochondrial Benzodiazepine Receptor in Traumatic Brain Injury: Therapeutic Implications
CNS & Neurological Disorders - Drug Targets In Search of the Most Suitable Lentiviral shRNA System
Current Gene Therapy Recent Advances and Perspectives in Liposomes for Cutaneous Drug Delivery
Current Medicinal Chemistry Circulating Levels of VCAM and MMP-2 May Help Identify Patients with More Aggressive Prostate Cancer
Current Cancer Drug Targets Stem Cells: Their Role in Breast Cancer Development and Resistance to Treatment
Current Pharmaceutical Biotechnology Targeting ErbB3: the New RTK(id) on the Prostate Cancer Block
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued)